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Effectiveness and moderators 
of individual cognitive behavioral 
therapy versus treatment as usual 
in clinically depressed adolescents: 
a randomized controlled trial
Yvonne Stikkelbroek 1*, Gerko Vink1, Maaike H. Nauta2, Marco A. Bottelier3, 
Leonieke J. J. Vet4, Cathelijne M. Lont5, Anneloes L. van Baar1 & Denise H. M. Bodden1,5
We examined if manualized cognitive behavioral therapy (CBT) was more effective than Treatment 
As Usual (TAU) for clinically depressed adolescents within routine care. This multisite Randomized 
controlled trail included 88 clinically depressed adolescents (aged 12–21 years) randomly assigned to 
CBT or TAU. Multiple assessments (pre-, post treatment and six-month follow-up) were done using 
semi-structured interviews, questionnaires and ratings and multiple informants. The primary outcome 
was depressive or dysthymic disorder based on the KSADS. Completers, CBT (n = 19) and TAU (n = 26), 
showed a significant reduction of affective diagnoses at post treatment (76% versus 76%) and after six 
months (90% versus 79%). Intention-to-treat analyses on depressive symptoms showed that 41.6% 
within CBT and 31.8% within the TAU condition was below clinical cut-off at post treatment and after 
six-months, respectively 61.4% and 47.7%. No significant differences in self-reported depressive 
symptoms between CBT and TAU were found. No prediction or moderation effects were found for 
age, gender, child/parent educational level, suicidal criteria, comorbidity, and severity of depression. 
We conclude that CBT did not outperform TAU in clinical practice in the Netherlands. Both treatments 
were found to be suitable to treat clinically referred depressed adolescents. CBT needs further 
improvement to decrease symptom levels below the clinical cut-off at post treatment.
Depression is identified as a rapidly growing epidemic disease that will be the leading cause of the global burden 
of disease in  20301. Even more worrisome, the highest incidence rate of depression is found during  adolescence2,3. 
Depression is also the predominant cause of illness and disability for youth aged 10 to 19  years1. Depressive 
disorders are a serious threat for adolescent mental health because of the high prevalence  rate4–7, high burden of 
 disease8 and high rate of  recurrence9,10. In addition, depressed adolescents showed an increased risk of suicide, 
as well as for social problems, delinquency, learning problems, substance abuse problems, physical problems, 
teen pregnancies and experiencing negative life  events10–12. Therefore, it is important that depressive disorders 
are treated effectively at an early  stage10,13.
Cognitive behavior therapy (CBT) and Interpersonal therapy (IPT) are identified as the psychological treat-
ments of choice besides  medication14,15. Different meta-analyses on the effectiveness of a broad range of psycho-
logical interventions for adolescent depression showed effect sizes ranging from small-to-moderate (0.34)16 to 
large (1.27)17. In a meta-analysis solely directed at the effectiveness of CBT in depressed youth, a medium effect 
size of 0.53 was  found18. A review of Watanabe and  colleagues19 showed that 50% of the adolescents did not meet 
criteria of a depression diagnosis after CBT compared to 35% in the TAU condition. Furthermore, a network 
meta-analysis (a novel approach that integrates direct and indirect evidence from randomized controlled stud-
ies) showed that CBT was significantly more effective than control conditions in treating depression in youth 
open
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(including placebo, waitlist, and treatment-as-usual)20. However, most studies included in these meta-analyses 
are efficacy studies, conducted in “ideal” and controlled circumstances. Such studies lack generalizability to 
“real-world” clinical practice, because their samples do not match the complex and severe cases seen in routine 
mental health  care16.
Although CBT is one of the most intensively studied psychological treatment of which efficacy is repeatedly 
established against a broad range of control conditions, it is still unclear if CBT can outperform an active treat-
ment condition within routine mental health care. It is suggested that highly structured and manualized CBT can 
be beneficial when confronted with complex client  conditions21. However, the effectiveness of CBT in clinically 
depressed adolescents referred to routine mental health care still needs to be established.
For this study, the CBT program “Coping with Depression course for Adolescents (CWD-A)”22 designed for 
groups, was translated into Dutch and adapted to an individual version, the “D(o)epression course”23,24. Several 
RCT’s have repeatedly shown that CWD-A is more effective than inactive control  conditions25–31 and treatment as 
 usual26, However, these results are also  inconclusive32. When comparing the results of several studies on CWD-A 
with an active control condition (which consisted of Care as usual, Interpersonal therapy or CWD-A plus a par-
ent training) for adolescents diagnosed with a depression, a small-to-moderate effect size of 0.35 was  found33. 
CWD-A is regarded as probably efficacious because studies were conducted by only one research group, solely 
within the American population and not with clinically referred  adolescents34. Research on clinically referred 
adolescents is necessary to enhance generalizability to clinical practice.
In addition, knowledge about possible moderators of treatment is desperately needed, but  scarce16,34. A 
systematic review of randomized or controlled depression studies concluded that predictors and moderators 
were investigated in only a few studies (n = 13) since 2000, and outcomes provided little consistent knowledge 
about  moderators21. It was concluded that gender, age, comorbidity, externalizing problems did not predict or 
moderate treatment results in depressed adolescents. Severity of depression and comorbid anxiety seem to be 
potential predictors of worse treatment  outcome21. However, comorbide diagnoses are often used as exclusion 
criteria in efficacy trials and therefore not studied thoroughly.
Another literature review on CBT treatment studies on depressive youth found that treatment outcome 
was predicted by age, general functioning, and number of diagnoses and moderated by family income and 
severity of  depression35. Inconsistency in findings may result from moderator relationships that are specific for 
one population, one outcome, one treatment or one specific moderator, but do not hold automatically in other 
 circumstances36. Despite this restriction, the study of potential moderators, such as age, gender, educational 
level of the child and the parent, suicidal criteria, as well as comorbidity and severity of depression, is relevant 
within routine mental health care, because it can reveal essential knowledge for the usefulness of CBT in specific 
populations.
In conclusion, the efficacy of CBT as treatment of clinically depressed adolescents is well established, but 
the effectiveness in routine mental health care in comparison to other psychotherapies is not yet clear. Also, 
potentially important moderators have not been studied in effectiveness trials.
In this study, a randomized controlled trial was conducted investigating the effectiveness of the individual 
CBT program the “D(o)epression course” compared to TAU in a sample of clinically referred adolescents with 
a Major Depressive Disorder or Dysthymic disorder according to DSM-IV-TR37. The aims of this study were to 
investigate the (1) effectiveness and (2) potential moderators and predictors (age, gender, educational level of 
the adolescent and the parent, suicide criteria, comorbidity and severity of depression) of CBT versus TAU (see 
Fig. 1). CBT was expected to be more effective than TAU (without CBT). No specific hypotheses were formulated 
concerning the moderators due to inconclusive findings on moderators in previous  research21,38.
Method
Study design. This study was designed as a multi-site (N = 14), randomized controlled clinical trial in which 
individual CBT was compared to Treatment as usual (TAU). Randomization was conducted after pre-treatment 
assessment and was executed per adolescent by computer generated block randomization and stratified per 
mental health care center by the primary researcher who did not conduct the interviews or any measurement. 
The study design is described in detail  elsewhere39. The study design was approved by the independent Medi-
cal Ethical Committee of Utrecht Medical Centre at Utrecht University, number 10/446 and all research was 
performed in accordance with relevant guidelines and regulations. The trial was preregistered at the Dutch Trial 
register (NTRnumber 2676 (03/01/2011); www.trial regis ter.nl).
The following assessments took place; prior to treatment (pretreatment assessment), within treatment (media-
tor assessments), immediately after treatment or after 15 sessions (post treatment assessment), six months after 
treatment (six-month follow-up) and 1 year after treatment (1 year follow-up). In this paper, we will present the 
post treatment and six-month follow-up results. Assessments were multi-method (semi-structured interviews, 
questionnaires and ratings) and involved multiple informants (adolescent, parent and therapist). Independent 
research assistants who were blind to condition conducted semi-structured interviews. Questionnaires were 
completed online using Survalyzer (an online questionnaire server) at home by the adolescent and the parents 
using a separate login code to secure privacy. The therapist completed the questionnaires at the office.
The primary outcome measure was presence of a depression diagnosis based on a semi-structured diagnos-
tic interview, the Kiddie-Schedule for Affective Disorders and Schizophrenia, present and lifetime  version40. 
Secondary outcomes included depressive symptoms, severity of depression, global functioning, suicide risk, 
and comorbidity.
Based on previous research an effect size (Cohen’s d) of 0.53 was  expected18. Power calculations in STATA 
indicated that 70 adolescents per condition (assuming an alpha of 0.05, a statistical power, 1-beta, of 0.80 and a 
drop-out of 20% would be required to detect a difference in depression diagnosis between conditions.
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Sample characteristics. In total, 103 referred clinically depressed adolescents, aged 12 to 21 and their 
parents (n = 71) were included in this study between 2011 and 2014 as planned. For a presentation of patient 
flow through the trial, see Fig. 2.
The participants were recruited from 14 different public mental health clinics geographically spread out over 
the Netherlands, from December 2011 to December 2014.
A total of 88 participants were randomized, their characteristics are shown in Table 1 and based on pre-
treatment data. The mean age of the participants was 16.6 years (SD = 2.1) and 71% was younger than 18 years. 
Most participants (92%) were of Dutch origin and 2.3% of other European countries, 1.4% of Iran, 1.4% African 
and 2.9% unknown. The majority (82%) of the adolescents was female.
If the adolescent was 18 years or older, parents were only approached after the adolescent’s permission. 
Participation of parents was not always possible because some adolescents (n = 14) above the age of 18 did not 
consent to the involvement of parents in the treatment or in the study. If both parents participated, we included 
the parent who filled out most questionnaires during the study and had the most complete assessments. In total 
71 parents were included, of which 10 had a child aged 18 or above. All participating parents were biological 
parents, their mean age was 48.4 (SD = 5.3) and 18.6% (n = 11) was male.
An experienced psychologist within the mental health center assessed the CDI-2 child and parent version to 
screen for depressive symptoms and informed the adolescents and their parents about the study. After written 
informed consent was given by the adolescent and his/her parents, a trained independent research assistant 
carried out the semi-structured diagnostic interview (KSADS) and checked whether the adolescent met the 
inclusion or exclusion criteria. The inclusion criteria were: (1) a primary diagnosis of Major Depressive Dis-
order or Dysthymic disorder, (2) age 12 to 21 years, and (3) referred to one of the participating mental health 
care institutions. The exclusion criteria were (1) acute suicide risk (2) substance abuse, pervasive developmental 
disorder, or bipolar disorder which required a different treatment approach (3) day care or admission to an 
inpatient clinical setting and (6) not fluent in Dutch, Turkish, Arabic or Berber language. If medication (for the 
depression or another disorder) was used in the CBT condition, the dosage at pre-treatment was kept constant 
during the intervention.
Interventions. CBT. The experimental treatment consisted of the D(o)epression  course24, which is an indi-
vidual CBT protocol based on the CWD-A23. This treatment was limited to 15 weekly sessions of 45 min with 
the adolescent.
In line with the CWD-A, the D(o)epression course is based on the social learning theory, which explains the 
etiology of depression, as was developed by Lewinsohn and  colleagues22. This theory states that there is a con-
nection between the number of positive interactions between a person and his environment on one hand, and 
depression on the other. A triggering event such as a stressful life event may cause a negative spiral of less positive 
interactions, which in turn leads to more negative thoughts and a deteriorating depressed mood. The intervention 
aims to reduce depressive complaints in adolescents with a depressive disorder. The focus of the intervention 
is broad, since depressive episodes are considered to be multi-factorially determined. The CBT treatment is 
described in detail per session (what, how, when and how long) in a manual for the therapist. A workbook for 
the participant with psychoeducation, exercises and worksheets was also provided. The intervention contains 
Figure 1.  Aims and potential moderators evaluated in this study.
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representative CBT  components41,42 namely: psycho-education (information about depression and the rationale 
for the etiology of the complaints and the treatment of them), setting attainable goals (translate large goals into 
realistic short term goals), self-monitoring (registration of the mood, activities and thoughts), activation (plan-
ning frequent, joyful activities), improving social skills and communication skills (improvement and stimulation 
Figure 2.  Participants flow chart.
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of social behavior), relaxation techniques, cognitive restructuring (identifying and changing unrealistic negative 
thoughts about the self, others and events), role play and problem solution skills (teaching the creation of solu-
tions for problems via brainstorm, choosing, trying and evaluating) and relapse prevention. The parents received 
psycho education and information on CBT after session three and nine. By the end of treatment a meeting with 
the parent(s) was scheduled to evaluate the treatment.
Treatment integrity was enhanced, by a standardized training in delivering the D(o)epression course and 
routine peer and expert supervision within the mental health care center.
TAU, the control treatment, for clinical depression was delivered by registered and qualified therapists spe-
cialized in different therapies. TAU consisted of 15 weekly sessions of 45 min until T1. A broad range of differ-
ent treatments and combinations were delivered within the control condition: IPT, family therapy, medication, 
psychodynamic therapy (short duration), (non-directive) counseling and Eye Movement Desesititation and 
Reprocessing (EMDR) for depression , solution focused. See results under Treatment received. The TAU thera-
pists received the same information about depressive disorders as the CBT therapists and were instructed not to 
use any CBT elements within the TAU condition. TAU treatment could continue after 15 sessions.
To enhance external validity, all sessions took take place within routine outpatient care in public mental 
health care institutions.
Treatment integrity was established by rating video and audio recordings of two randomly chosen sessions 
per treatment. Two trained psychologists performed these ratings. A treatment integrity scale was developed 
containing three factors, namely quality of the therapist (e.g. empathy, motivating client, instigating interaction, 
avoiding depressive talk), content of treatment (e.g. following protocol, attaining goals, instigate exercise like 
role play, modeling, providing feedback) and structure of the session (e.g. setting agenda, following time sched-
ule, efficient use treatment time). Items were rated on a three-point scale (0 = absent, 1 = minimal, 2 = largely, 
3 = maximal). Interrater reliability was established by rating the same sessions (n = 8) by the observers and a 
supervisor specialized in this protocol. The Intraclass Correlation Coefficient (ICC) was 0.92, which indicates 
excellent interrater reliability. The mean score on the treatment integrity was 2.68 (SD = 0.75) indicating that 
treatment integrity was good.
Therapists. Treatments in both conditions were delivered by psychologists with at least one year of experi-
ence within professional mental health care. The therapist in the CBT condition had also at least one year of 
experience in conducting CBT. Therapists were not allowed to conduct treatments in both conditions.
In the CBT condition 37 therapists participated, and in the TAU condition 37 other therapists participated. 
Their mean age was 42.78 (SD = 11.47), 68.2% was female, most (98.6%) were originally Dutch, white Caucasian, 
and had on average 16.3 (SD = 7.16) years of experience. No differences were found for these therapist charac-
teristics between both conditions.
Table 1.  Sample characteristics at pre-treatment and pre-treatment comparison between CBT and TAU. 
CDI-II = Child Depression Inventory-II; CGI-S = Clinical Global Impression-severity scale; CGAS = Children 
Global Assessment Scale; SCA = Suicide Criteria Assessment; CBT = Cognitive-Behavioral Therapy; 
TAU = Treatment as Usual. *p ≤ .05, **p ≤ .01.
Characteristics at pre-treatment n CBT n TAU Test statistic
Female, n (%) 44 34 (77.3) 44 38 (86.4) χ2 = 1.22
Age, mean (SD) 44 16.9 (2.2) 44 16.3 (2.0) t = − 1.27
Dutch nationality, n (%) 41 39 (95.1) 43 42 (97.7) χ2 = 0.40
Education level parents, n (%) 35 32 χ2 = 16.73**
Primary education only 1 (2.9) 0 (0.0)
Secondary education: Low level 0 (0.0) 7 (21.9)
 Middle level 14 (40.0) 9 (28.1)
 High level 18 (51.4) 10 (31.3)
 University 2 (5.7) 6 (18.7)
Education level children, n (%) 37 40 χ2 = 4.22
Secondary education: Special education 2 (5.4) 1 (2.5)
 Middle level 16 (43.2) 14 (35.0)
 High level 17 (46.0) 24 (60.0)
 University 2 (5.4) 1 (2.5)
History of mental health service use, mean (SD) 35 2.8 (0.7) 40 2.7 (0.6) t = − 1.20
Depression (CDI-II child version) mean (SD) 34 27.1 (8.7) 36 24.1 (6.7) t = − 1.62
Depression (CDI-II parent version), mean (SD) 28 26.9 (8.0) 29 24.8 (6.4) t = − 1.11
Depression severity (CGI-S) mean (SD) 37 4.16 (0.9) 37 3.92 (1.3) t = − 0.95
Global functioning (CGAS), mean (SD) 37 49.5 (9.7) 35 49.4 (8.1) t = − 0.08
Suicide criteria (SCA), mean (SD) 37 4.5 (3.9) 40 3.6 (3.2) t = − 1.19
Number comorbid diagnoses, mean (SD) 41 0.83 (1.) 44 1.25 (1.8) t = − 1.28
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The therapists within the CBT condition were in general CBT oriented (n = 27, 72.97%), eclectic (n = 9, 24.3%) 
or cognitive oriented (n = 1, 2.7%). Of these therapists, nine (23.4%) were registered as a CBT therapist. The thera-
pists in the CBT condition received a two day training in delivering the D(o)epression course by the first author.
The overall orientation of TAU therapists was eclectic (n = 12, 32.4%), cognitive (n = 12, 32.4%), psycho-
dynamic (n = 9, 24.3%), family based (n = 2, 5.4%) or another orientation (n = 2, 5.4%). Therapists in the TAU 
condition did not have CBT as a primary orientation of treatment.
Instruments. The primary outcome measure was presence of a major depression or dysthymic diagnosis, 
assessed by a semi-structured diagnostic interview, the Kiddie-Schedule for Affective Disorders and Schizo-
phrenia, present and lifetime version (K-SADS)43,44. The K-SADS assesses a wide range of diagnoses (present 
and life time). The view of the adolescent, the parent and the independent clinician were taken into account in 
the final diagnosis, expressed as diagnosis present (yes) or absent (no). In previous research, the concurrent and 
convergent validity of the K-SADS was  supported40,43, the interrater agreement was high (range: 93% to 100%) 
and test –retest reliability alpha coefficients were excellent (0.77 to 1.00)43.
As secondary outcome measures depressive symptoms, severity and global functioning, suicide risk, and 
comorbidity were used.
The degree of depressive symptoms was measured by means of self-report using the Child Depression Inven-
tory-II (CDI-2)45,46. The CDI-2 is a revision of the  CDI47,48, which was translated in  Dutch45. The CDI-2 child 
version consists of 28 items, which assess cognitive, affective and behavioral symptoms of depression in the past 
two weeks. Each item has three graded alternatives of which one is chosen (e.g., “0 = I feel like crying once in 
a while, 1 = I feel like crying many days, 2 = I feel like crying every day”). Higher scores reflect more depressive 
symptoms. The reliability of the CDI-2 total score was good in the current study (α = 0.82).
The CDI-2 also provides a parent  version46, which contains 17 items. Parents have to indicate how often the 
adolescent has experienced cognitive, affective and behavioral symptoms in the past two weeks on a Likert scale 
ranging from 0 (not at all) to 4 (most of the time). The reliability of the total scale in de current study was good 
(α = 0.78).
Severity of depression was rated by the therapist on the one item Clinical Global Impression-severity scale 
(CGI-S)49 with a scale range from 1 (no complaints) to 7 (most severe depressive complaints).
Global functioning of the adolescent was assessed by the therapist on the Children Global Assessment Scale 
(CGAS)50,51. The therapist rated the overall quality of functioning of the adolescent in several contexts namely 
at home, at school, with friends and during leisure time. The scale contains one item and the scores range from 
0 (extremely impaired functioning) to 100 (very good functioning).
Suicide criteria were assessed with the Suicide Criteria Assessment (SCA)52. The scale was constructed based 
on the Suicidal Ideation  Questionnaire53 and the Columbia-Suicide Severity Rating  scale54. The scale contains 
five questions including “I thought about killing myself ” or “I thought about planning to kill myself ”. These 
questions tap into different aspects of suicidal criteria such as the frequency of thoughts, wishes, plan and urges 
to perform action within the past two weeks on a scale from 0 (not at all) to 2 (nearly every day). The reliability 
of the SCA is good (α = 0.89).
Comorbid psychopathology was assessed on two levels namely on diagnosis level with the K-SADS (present or 
absent) and on symptom level with the Youth Self Report scale (YSR)55 for adolescents and the Child Behavior 
Check List (CBCL) for  parents55,56. The YSR and CBCL use a three point Likert scale (0 = not true, 1 = somewhat 
or sometimes true, and 2 = very true or often true). A higher score indicates more symptoms of psychopathology. 
The YSR and the CBCL allow a distinction between internalizing and/or externalizing psychopathology. Reli-
abilities for the YSR internalizing problems (α = 0.79) and externalizing problems (α = 0.86) were good, as were 
the reliabilities for the CBCL scale for internalizing (α = 0.87) and externalizing (α = 0.85) problems.
Demographic information was gathered by questions about age, gender, ethnicity, education level and family 
income.
Statistical analysis. All missing values were imputed at item and assessment level, except for the semi-
structured interview. Imputations were generated in R version 3.2.157 with package MICE version 2.2258. The 
imputation routine was tailor-made to the analysis problem and the predictor matrix and imputation method 
are optimized for efficiency. Initially, for each incomplete variable, the 10 best predictors were selected. Where 
needed, this selection has been extended to make the imputation model compatible to the analysis model. The 
experimental condition was always included as a predictor. Ten imputed datasets were generated with 25 itera-
tions for the algorithm to converge.
Predictive mean  matching59 was used as the imputation routine for continuous and categorical data. Predic-
tive mean matching draws imputation from the observed data and is known to preserve patterns and relations 
that are present in the  data60. Variables that contained bonafide missings, such as items that are not applicable 
for a particular respondent, were imputed with a custom adaptation of predictive mean matching. The analyses 
were pooled based on Rubin’s  rules61 following the work  from62. Intent-to-treat as well as completer analyses 
were conducted on the secondary measures.
Pre-treatment differences were analyzed with chi-square tests for dichotomous variables and t-test for con-
tinuous variables. Within group effects were examined by looking at the percentage of adolescents that did not 
meet the required criteria of the depressive or dysthymic disorder as indicated by the K-SADS. Continuous 
variables were analyzed using paired t-tests. To calculate the effect sizes within the conditions, the formula 
described in Dunlap, Cortina, Vaslow, and  Burke63 was used. The criteria used to interpret the effect sizes (g) 
were: 0.10 = small, 0.30 = small-to-moderate and 0.50 = a large  effect64. Clinical significance was established by 
7
Vol.:(0123456789)
Scientific RepoRtS |        (2020) 10:14815  | https://doi.org/10.1038/s41598-020-71160-1
www.nature.com/scientificreports/
examining the percentage of adolescents falling below the clinical cut-off score of 14 for the CDI-2 for the child 
 version45,46, and 17 for the parent  version46.
Between group effects were analyzed with chi-square tests on the percentages of adolescents that did not meet 
all criteria of the depressive or dysthymic as indicated by the K-SADS. Between group effects for continuous 
variables at post treatment and 6 month follow-up were evaluated, using ANCOVAs with pre-treatment scores 
as a covariate to control for pre-treatment differences, as  recommended65,66. TAU versus CBT effect sizes were 
computed as described by Hedges and  Olin67 using a statistical software package named Comprehensive Meta-
analysis, version 3.3.070.
Moderation was analyzed by multi-group analyses for dichotomous variables and linear regression analyzes 
for adolescent or parent reported continuous variables. In view of the number of participants in relation to the 
number of variables, separate analyses had to be used. Moderation was studied by separate linear regression 
analyses for condition on adolescent or parent reported depressive symptoms at post treatment and at 6 month 
follow-up while controlling for pre-treatment depressive symptoms and adding a potential predictor and the 
interaction variable. The tested potential predictors and moderators were adolescent age, adolescent gender, 
adolescent and parent education level, suicidal criteria, adolescent and parent reported comorbid externalizing 
problems, and therapist rated depression severity.
Results
Sample. The level of depressive symptoms reported by the adolescent (N = 70) on the CDI-2 at pre-treatment 
was high (M = 25.6; SD = 7.8), considering the cut-off score of 14, therefore the participants scored high above the 
level of clinical significance (Kovacs, 2011). More than half of the participants had at least one-comorbid diagno-
sis (58%, n = 49) on the semi-structured interview (N = 85). Most frequent disorders were Social phobia (n = 21, 
25%), Generalized Anxiety Disorder (n = 23, 27%), Specific Phobia (n = 7,8%), Panic Disorder (n = 5, 6%), Sepa-
ration Anxiety Disorder (n = 4, 5%), Post Traumatic Stress Disorder (n = 6, 7%), Attention Deficit Hyperactivity 
Disorder (n = 11, 13%) and Oppositional Defiant Disorder (n = 3, 4%). On the K-SADS, 72% (n = 61) reported 
thinking about death and 58% (n = 49) about suicidal ideation. Half of the sample had previous experience with 
mental health services (53%, n = 45).
Pre-treatment differences in the non-imputed data are reported in Table 1. Groups did not differ significantly 
on gender, age, ethnicity, history of mental health care use, internalizing- or externalizing problems (YSR/CBCL), 
depressive symptoms (CDI-2), pre-treatment number of diagnoses (K-SADS), suicide criteria assessment (SCA), 
global functioning (CGAS) or severity of depression (CGI-S). The chi-square test showed that only parental level 
of education in the CBT condition was significantly higher than in the TAU condition. Overall, randomization 
can be considered as succeeded.
Treatment received. The number of treatment sessions in both conditions between pre- and post treat-
ment assessment did not differ (MTAU  = 12.8, SD = 5.5; MCBT = 12.7, SD = 4.8). At pre-treatment, 9% of the adoles-
cents in the CBT condition and 13.6% in the TAU condition already received antidepressants, a nonsignificant 
difference. See the result section treatment received. The content of Treatment as Usual is provided were eclec-
tic 40.9% (n = 18), IPT 25% (n = 11), Eye Movement Desensitization and Reprocessing 11.4% (n = 5), Solution 
focused therapy 2.3% (n = 1), Family therapy 2.3% (n = 1), group counseling 2.3% (n = 1), medication only 2.3% 
(n = 1) and some did not start treatment 13.6% (n = 6). Within the TAU condition 11% (n = 5) changed to treat-
ment with medication only during treatment.
Drop-out and adverse events. In CBT, more adolescents (57%, n = 25) discontinued treatment compared 
to TAU (41%, n = 18), but this difference was not significant (χ2(2) = 2.236, p = 0.327). Of these drop-outs, 22 
(50%) in the CBT group and 16 (36%) in the TAU group dropped out during treatment. Different reasons led to 
discontinuation of treatment. In TAU, the reasons for discontinued treatment were elevation of depressive symp-
toms (38.8%, n = 7), lack of motivation (33.8%, n = 6), and reason unknown (27.7%, n = 5). In the CBT condition, 
discontinuation of treatment occurred because of change to another psychological intervention (28%, n = 7), 
reason unknown (24%, n = 6), elevation of depressive symptoms (20%, n = 5), change to medication (16%, n = 4) 
and lack of motivation (12%, n = 3).
Adolescents who discontinued CBT or TAU did not differ in gender or education level. However, an inde-
pendent-samples t-test showed a significantly higher level of pre-treatment depressive symptoms on the CDI-2 
in the CBT participants who discontinued treatment (MCBT = 29.3, SD = 9.0) compared to participants that dis-
continued TAU (MTAU  = 22.9, SD = 6.9), t(29) = -2.2, p = 0.04, partial eta squared = 0.4).
Three adverse events occurred in the CBT condition (and none in the TAU condition), that is two suicide 
attempts (4.5%) before session 5, and one participant committed suicide (2.2%) between 6 month follow-up and 
1 year follow-up. In the latter case, the therapist and parents had observed good response to CBT and a mainte-
nance dosage of medication was given as recommended by the Dutch clinical  guidelines68.
Treatment effectiveness. Primary outcome. The clinical diagnostic interviews (KSADS) were conduct-
ed with 54 adolescents (61%) at post treatment, and with 39 (38%) at follow-up. Within the CBT condition, 76% 
(n = 19) of the treatment-completing adolescents did not meet criteria for depressive or dysthymic disorder on 
the K-SADS at post treatment and 88% (n = 18) at 6 month follow up. Within the TAU condition, these percent-
ages within completers were 76% (n = 22) and 79% (n = 15) respectively.
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Secondary outcome. Paired-samples t-tests, two sided, were conducted to measure change within the CBT and 
TAU condition on secondary outcome measures reported by adolescent, parent or therapist and between pre- 
and post and pre and 6 month follow-up treatment. Effect sizes are reported in Table 2.
Intent to treat analyses on imputed data showed a statistically significant decrease on depressive symptoms 
(CDI-2) reported by the adolescent within both conditions, respectively within the CBT condition pre-post 
(t(96) = 5.9, p < 0.001) and pre- to 6 month follow-up (t(54) = 9.2, p < 0.001) and the TAU condition pre-post 
(t(39) = 4.06, p < 0.001) and pre-6 month follow-up (t(34) = 8.14, p < 0.001). The effect sizes varied from moder-
ate to large, see Table 2. Also, a clinically significant reduction in depressive symptoms (below the cut off score 
on the CDI-2) at post treatment was reached in 41.6% (n = 18) of the cases within the CBT condition and 31.8% 
(n = 14) within the TAU condition. At 6 month follow-up, 61.4% (n = 27) within the CBT and 47.7% (n = 21) 
within the TAU condition had a CDI-2 score below the clinical cut-off score.
Intent to treat analysis showed a significant decrease in parent report of adolescent depressive symptoms 
within the CBT condition from pre to post (t(21) = 3.48, p = 0.002) and pre to 6 month follow-up treatment 
(t(15) = 5.99, p < 0.001), with a moderate and large effect size respectively. A significant decrease was also found 
within the TAU condition, pre-post (t(18) = 3.81, p = 0.001) and pre-6 month follow-up (t(22) = 7.22, p < 0.001), 
with large effect sizes. Parents reported a clinically significant reduction in depressive symptoms in their child 
at post treatment in 35.9% (n = 16) within the CBT condition and 39.8% (n = 18) within the TAU. At follow-up, 
52.5% (n = 23) within CBT and 61.8% (n = 27) within TAU condition had a CDI-2 score below the clinical cut-
off score.
Ratings from the therapist showed that depression severity decreased while global functioning of the adoles-
cent increased from pre to post treatment, with large effect sizes in both conditions (see Table 2).
Comorbid suicide criteria reported by the adolescent within CBT (t(132) = 2.97, p = 0.004) dropped signifi-
cantly at post treatment but not in the TAU condition. At 6 month follow-up within both conditions a decrease 
in suicide criteria was found, respectively CBT (t(48) = 4.55, p < 0.001) and TAU (t(243) = 5.79, p < 0.001).
Internalizing symptoms (YSR) reported by the adolescent were also significantly reduced within both treat-
ments, respectively within the CBT condition pre-post (t(62) = 4.56, p < 0.001) and pre- to 6 month follow-
up (t(44) = 7.66, p < 0.001) and TAU condition pre-post (t(61) = 4.53, p < 0.001) and pre-6 month follow-up (t 
(46) = 5.96, p < 0.001).
Comorbid externalizing problems reported by the adolescent decreased significantly from pre- to 6 month 
follow-up, within CBT (t(38) = 2.98, p = 0.005) as well as in TAU(t(130) = 3.34, p = 0.001). Only parents in the 
TAU condition reported a significant decrease of externalizing symptoms from pre to follow-up1 (t(13) = 2.46, 
p = 0.021), while parents in the CBT condition reported no significant change.
Effectiveness of CBT versus TAU . Primary outcome. Treatment completer analyses (NTAU  = 29, 
NCBT = 25) were performed. Chi-square tests were done to measure differences in the percentage of adolescents 
who did not meet all the criteria for depressive or dysthymic disorder. No significant difference was found be-
tween TAU and CBT at post treatment, χ2(1) = 0.000, p = 0.99 nor at follow-up1, χ2(1) = 0.914, p = 0.339.
Secondary outcomes. Between groups comparisons were conducted, using ANCOVAs with pre-treatment 
scores as a covariate, see Table 2. No main effect of condition was found on self-reported and parent reported 
depressive symptoms at post treatment, nor at 6 month follow-up. The effect sizes for pre-post and pre-6 month 
follow-up scores between the conditions were respectively small and very small, see Table 2. Also, no significant 
main effects of condition were found at post treatment or 6 month follow-up on the following variables; therapist 
rated depression severity and global functioning, adolescent reported suicide criteria and adolescent and par-
Table 2.  Within and between condition pooled pre-posttreatment and pre-follow-up1 treatment effect 
sizes (g) for Adolescent (n = 88 ~) and Parent (n = 88 ~) Questionnaires. CDI-2 = Child Depression Inventory 
II; Child = child version; Parent = Parent version; CGI-S = Clinical Global Impression-severity scale; 
CGAS = Children Global Assessment Scale; SCA = Suicide Criteria Assessment; YSR = Youth Self Report 
scale; INT = internalizing problems; EXT = externalizing problems; CBCL = Child Behavior Check List; 
CBT = Cognitive-Behavioral Therapy; TAU = Treatment As Usual. ~ Data were multiple imputed. a No 6-month 
follow-up measurements of the CGAS and CGI-S were collected. *p < .05, **p < .01, ***p < .001.
Scale
Pre-post Pre-6-month follow-up
CBT (g) TAU (g) CBT-TAU(g) CBT (g) TAU (g) CBT-TAU (g)
CDI-II Child 0.92*** 0.69*** 0.20 1.37*** 1.37*** 0.09
CDI-II Parent 0.47** 0.71** − 0.18 0.91*** 1.15*** − 0.15
CGI-Sa 0.77** 1.14*** − 0.26 –– – –
CGASa 0.58** 1.07*** − 0.27 – – –
SCA 0.48** 0.26 0.08 0.05*** 1.13*** − 0.40
YSR INT 0.70*** 0.83*** 0.01 1.31*** 1.22*** 0.15
YSR EXT 0.19 0.34 − 0.25 0.96** 0.60** − 0.17
CBCL INT 0.10 0.55** − 0.55 0.67*** 1.00*** − 0.32
CBCL EXT 0.05 0.11 − 0.29 0.09 0.44* − 0.29
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ent reported internalizing and externalizing symptoms. Effect sizes varied between almost zero for adolescent 
reported internalizing problems at post treatment to moderate (0.55) for parent reported internalizing problems 
at post treatment between the two conditions.
Predictors and moderators. Potential predictors and moderators were analyzed with linear regression 
analyses, with adolescent and parent reported depressive symptoms as the dependent variables. The following 
variables were included: adolescent age, adolescent gender, adolescent and parent education level, suicidal risk, 
adolescent and parent reported comorbid externalizing problems, and therapist rated depression severity. No 
significant predictors or moderators were identified.
Discussion
In this study, CBT was compared to an active treatment condition (TAU), under rigorous conditions within 
routine care institutions and with a referred clinical sample of adolescents diagnosed with depression or dys-
thymia. Results can be summarized as follows. Both treatments showed a significant decrease in the percentage 
of adolescents who met the criteria for a depressive or dysthymic disorder as well as a significant decrease in 
self-reported and parent reported depressive symptoms with large effect sizes. No significant differences were 
found between the two conditions in depression diagnosis or on adolescent and parent reported depressive 
symptom level, both at post treatment or at six month follow-up. Also, no significant differences were found 
between CBT and TAU on therapist reported depression severity and global functioning, suicide criteria, and 
adolescent reported internalizing and externalizing comorbid symptoms. Although not significant, more adverse 
events occurred in CBT compared to TAU. No predictors or moderators of treatment were found regarding age, 
gender, educational level adolescent and parent, comorbidity and severity of depression.
The finding that treatment in both conditions showed a decrease in number of depression diagnoses and a 
clinically significant symptom reduction in this specific sample is reassuring.
The outcome of CBT treatment in a large RCT, the Treatment Adolescent Depression Study (TADS), con-
ducted with a community recruited sample (n = 327) was found to be worse when severity of depression and 
comorbidity were  high38. This could implicate that the outcome of CBT in a more severe and complex sample 
like ours, could be small. However, we did find a large effect size (ES = 0.92) at post treatment for CBT.
We hypothesized that CBT would outperform TAU, but it did not. Previous research showed that the group 
manual of CWD-A outperformed TAU in several RCT’s (n = 3)33. However, the finding of this study is in line 
with the results of a more recent meta-analysis showing that evidence-based protocols do not outperform usual 
care in clinically referred samples or in youths with a diagnosis, including  depression70.
Several explanations for these contradictory findings can be provided. First, in our study, the control condi-
tion was TAU. In general, the quality of TAU is considered an important influential factor on the results of a 
RCT and specifically for effectiveness of  CBT71. Moreover, structural aspects (such as number and duration of 
sessions, training of therapist, format of therapy and restriction of topics) have been shown to be important for 
the proportion of established effectiveness in placebo  studies72. In our study, the quality of TAU was high. The 
therapists who performed TAU treatments in this study were highly qualified and were experienced in tailoring 
the treatment to the individual’s needs and discuss more broad topics than was allowed in CBT. Furthermore, 
the TAU consisted of a substantial amount of evidence-based treatments for depression, for instance IPT and 
anti-depressant medication or a combination of both. It is known that CBT does not outperform these evidence-
based treatments. For example, CBT did not outperform  IPT20 and medication outperformed CBT as acute 
 treatment73. Besides, TAU in routine mental health care is also considered to be a stronger standard to test 
manualized protocols than other control  conditions70.
Second, the treatment dose could not be kept equal in both conditions after post treatment. Some TAU treat-
ments continued after 15 sessions in contrast to the CBT treatment, which ended after 15 sessions. Continuation 
of CBT after 15 sessions was a reason to drop-out of the study. It is possible that TAU needed more sessions 
to reach the level of decrease in depressive symptoms between post treatment and follow-up after six months. 
Another possibility is that the amount of reduction in depressive symptoms could partially be explained by the 
natural course of depression in participants in both treatment conditions. Spontaneous reduction of depres-
sive symptoms can occur even without treatment after eight months, the mean duration of a major depressive 
 disorder13.
Third, the amount of comorbid diagnoses was substantial in both conditions and interfered with CBT treat-
ment delivery. In this study, the CBT manual did not allow for adaptations to address comorbidity. In the TAU 
condition the therapists were free to treat comorbid diagnoses as well, next to treating the depression. The content 
of TAU treatments compared to CBT may target behavior problems more specifically, which might be related 
to irritable mood as a characteristic of depression and therefor important to the treatment of depression. For 
example, parents in the TAU condition reported a significant decrease of externalizing symptoms at post treat-
ment, whereas parents in the CBT condition did not.
Furthermore, one-third of the adolescents discontinued CBT treatment and changed to another psychologi-
cal treatment. TAU perhaps is better equipped to address comorbidity by adding other psychological treatment 
elements. Previous research found that the highly flexible CBT treatment containing different components used 
in the TADS study did not result in a better response rate namely 48% after 12 weeks and 65% after 18 weeks 
on the CGI-I72. However, discontinuation of CBT treatment in the TADS study was much lower than in the 
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Fourth, another explanation is the adaptation of the group-based manual of CWD-A into an individual based 
manual without any peer interaction which could have influenced effectiveness. Group treatments are considered 
to work better than individual treatment in depressed  teens42.
Fifth, last but not least, common factors (alliance, empathy, expectations and therapist differences) were active 
in both conditions. Evidence from a large review supports that common factors contribute to the benefits of a 
 treatment74. Therefor the common factors should also be considered as a possible explanation for the outcome 
instead of the specific ingredients of CBT or TAU.
Since no differences in effectiveness were found, we still need to determine which treatment a therapist pref-
erably should use when dealing with adolescent depression. There are several factors that may be considered 
for this decision.
Besides effectiveness, this study examined possible moderators of treatment, which could be indicative of 
selecting a specific treatment for a specific patient. Search for moderators is important in order to identify sources 
of individual differences in treatment response and guide differential treatment selection. However, no effect of 
moderators could be established and thereby no specific group whom benefited more from CBT could be identi-
fied. The sample size (low power) may be accountable for this  result38. Apart from sample size another statistical 
reason should be considered.  Kraemer36 pointed out that research on a heterogeneous population with major 
individual differences is more likely to find moderators with a sensitive measure for individual  differences21,36. 
However, the group within this study was rather homogeneous with regard to demographics and diagnoses 
which decreases the chance of identifying a moderator. For instance, the education level of the participants was 
not significantly different between the experimental and control condition and variance within the condition 
was rather small.
Apart from moderators, cost-effectiveness of different treatments could also form a factor to take into account 
when choosing for a specific treatment. The cost effectiveness of CBT versus TAU will be presented in a forth-
coming paper and was not further examined for this paper.
Also, speed of symptom reduction within both conditions is important for the selection of treatments. Depres-
sion in adolescents should be treated as soon as possible and aggressively in order to shorten the depressive 
 period68. Reduction of the time to response has the potential to diminish the risk for suicide, functional impair-
ment, substance abuse and problems at school and work as much as  possible69. In future research, trajectories 
of treatment response should be analyzed.
Future research should also address mediators of outcome in CBT and TAU. For instance, reduction of nega-
tive thoughts by cognitive restructuring may mediate the relation between pre and post treatment depressive 
symptoms in the CBT condition.
A finding of serious concern was the high level of self-reported depressive symptoms at the time of referral. 
Of the adolescents 53% already received treatment before entering the mental health center. Although mental 
health treatment of children under 18 is free of charge in the Netherlands, a significant amount of depressed 
adolescents only sought treatment when depression was already severe. The dissemination and organization of 
effective treatment still needs attention to reach out to depressed adolescents in time.
This study also has several limitations. First, our sample size was not as big as was advised by our power 
calculation. We included 88 adolescents while the power calculation recommended 140 adolescents. Also, the 
effect size of TAU in mental health institutions in the Netherlands was found to be larger than TAU in studies 
conducted in other countries and settings on which the power calculations were based. As a result the power of 
the study was not as high as preferred.
Second, the amount of participants with a low education level or with a different ethnic background was 
small. Even though this is representative for the population in youth mental health care in the Netherlands, the 
generalization of the findings is limited to this particular group.
Third, even the adolescents and parents who decided to participate in the study were found to be hesitant to 
participate due to the extra assessments. Although assessments were conducted online and were easy to monitor, 
it was difficult to reach full response of all participants.
Fourth, TAU was not limited to 15 sessions. The number of sessions in TAU after post treatment (15 sessions) 
is not clear because the therapists sometimes did not register the forms completely. The total amount of face-
to-face contact between post treatment and followup1 was probably larger within TAU than in CBT. This could 
have influenced the increased effect size in TAU.
Fifth, the participating institutions in this study may have differed in various ways, including in priority and 
affinity to conduct research. This may have affected the  findings70.
Sixth, last but not least, common factors (alliance, empathy, expectations and therapist differences) were active 
in both conditions. Evidence from a large review, supports that common factors contribute to the benefits of a 
 treatment74. Therefor the common factors should also be considered as a possible explanation for the outcomes 
instead of the specific ingredients of CBT or TAU. This is also important compared to studies using waitlist 
control groups, where common factors are not active in both  conditions74.
Conclusion
Treatment of depression or dysthymic disorders in adolescents between 12 and 21 years with CBT or TAU showed 
a significant reduction of depressive diagnoses as well as in the number of depressive symptoms. However, more 
than half of the completers in CBT and TAU condition still had an elevated level of depressive symptoms at post 
treatment. CBT did not outperform TAU in this complex and severe clinical sample. No moderators of treat-
ment outcome were found.
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Further studies are needed to establish cost-effectiveness of treatments and to identify mediators in order to 
improve treatment effectiveness by permitting personalizing treatment to address comorbidity in a systematic 
way.
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